Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic cancer: Update on the PREOPANC-2 study
Abstract
Background: The recent Dutch PREOPANC-1 study demonstrated that neoadjuvant gemcitabine based chemoradiotherapy (CRT) followed by adjuvant gemcitabine has a superior radical resection rate and survival outcomes compared to upfront resection in patients with (borderline) resectable pancreatic cancer ((B)RPC). Potentially, neoadjuvant FOLFIRINOX could further improve these Results. The PREOPANC-2 study aims to investigate whether neoadjuvant...
Paper Details
Title
Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic cancer: Update on the PREOPANC-2 study
Published Date
Jan 1, 2020
Journal
Volume
22
Pages
S277 - S277
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History